In models of CT26 CRC cells and B16-F10 melanoma cells, targeting PIK3C3 with SAR405 inhibited autophagy, significantly decreased tumor growth, and improved mouse survival by inducing the infiltration of natural killer, CD8+, and CD4+ T effector cells [105]. This evidence concerns the gene PIK3C3 and neoplasm.